Birte Wistinghausen

1.1k total citations
29 papers, 705 citations indexed

About

Birte Wistinghausen is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Birte Wistinghausen has authored 29 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in Birte Wistinghausen's work include Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Polyomavirus and related diseases (6 papers). Birte Wistinghausen is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Polyomavirus and related diseases (6 papers). Birte Wistinghausen collaborates with scholars based in United States and Canada. Birte Wistinghausen's co-authors include Chien‐Kuo Lee, R. Gertner, David T. Levy, Ramón Gimeno, Ronald A. DePinho, Regina Raz, Kenichi Takeshita, Thomas G. Gross, Carl E. Allen and Michelle L. Hermiston and has published in prestigious journals such as Immunity, Transplantation and British Journal of Haematology.

In The Last Decade

Birte Wistinghausen

26 papers receiving 696 citations

Peers

Birte Wistinghausen
Naoki Sakata Japan
Federica Galaverna Italy
Silvy Lachance Canada
Janet Poole South Africa
Abraham S. Kanate United States
Pierre Péterlin France
Riad El Fakih Saudi Arabia
Javier López‐Jiménez Spain
Tulio E. Rodriguez United States
Kyung‐Nam Koh South Korea
Naoki Sakata Japan
Birte Wistinghausen
Citations per year, relative to Birte Wistinghausen Birte Wistinghausen (= 1×) peers Naoki Sakata

Countries citing papers authored by Birte Wistinghausen

Since Specialization
Citations

This map shows the geographic impact of Birte Wistinghausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birte Wistinghausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birte Wistinghausen more than expected).

Fields of papers citing papers by Birte Wistinghausen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birte Wistinghausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birte Wistinghausen. The network helps show where Birte Wistinghausen may publish in the future.

Co-authorship network of co-authors of Birte Wistinghausen

This figure shows the co-authorship network connecting the top 25 collaborators of Birte Wistinghausen. A scholar is included among the top collaborators of Birte Wistinghausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birte Wistinghausen. Birte Wistinghausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wistinghausen, Birte, Donald A. Barkauskas, Lauren Saguilig, et al.. (2024). Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study. Blood Advances. 8(5). 1116–1127. 6 indexed citations
2.
Roth, Kristina, Michael D. Keller, B Hammer, et al.. (2024). Implementation of a tier system for IVIG indications to address IVIG shortage at a tertiary care pediatric medical center. Pediatric Blood & Cancer. 71(4). e30871–e30871. 5 indexed citations
3.
Cheng, Jinjun, Birte Wistinghausen, & A. Yasmine Kirkorian. (2024). Pediatric Cutaneous T‐Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses. Pediatric Dermatology. 42(1). 11–21.
4.
Esbenshade, Adam J., Lisa S. Kahalley, Birte Wistinghausen, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Young investigators. Pediatric Blood & Cancer. 70(S6). e30567–e30567.
5.
El‐Mallawany, Nader Kim, Sarah Alexander, Mark Fluchel, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma. Pediatric Blood & Cancer. 70(S6). e30565–e30565. 8 indexed citations
6.
Rubinstein, Jeremy D., et al.. (2023). Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults. Best Practice & Research Clinical Haematology. 36(1). 101446–101446. 17 indexed citations
7.
Hermiston, Michelle L., et al.. (2023). How I approach B‐lymphoblastic lymphoma in children. Pediatric Blood & Cancer. 70(8). e30401–e30401. 1 indexed citations
8.
Cheng, Jinjun & Birte Wistinghausen. (2023). Clinicopathologic Spectrum of Pediatric Posttransplant Lymphoproliferative Diseases Following Solid Organ Transplant. Archives of Pathology & Laboratory Medicine. 148(9). 1052–1062. 3 indexed citations
9.
Esbenshade, Adam J., Lisa S. Kahalley, Reto M. Baertschiger, et al.. (2019). Mentors’ perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 66(10). e27920–e27920. 5 indexed citations
10.
Jordan, Michael B., Carl E. Allen, Jay Greenberg, et al.. (2019). Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatric Blood & Cancer. 66(11). e27929–e27929. 215 indexed citations
11.
McLaughlin, Lauren P., et al.. (2016). Management of post-transplant lymphoproliferative disorders. Current Opinion in Pediatrics. 29(1). 34–40. 22 indexed citations
12.
Meyer, Julia A., Delu Zhou, Clinton C. Mason, et al.. (2016). Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues. Pediatric Blood & Cancer. 64(7). e26363–e26363. 10 indexed citations
13.
Weintraub, Lauren, Tamir Miloh, Umesh Joashi, et al.. (2014). Identifying Predictive Factors for Posttransplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients With Epstein-Barr Virus Viremia. Journal of Pediatric Hematology/Oncology. 36(8). e481–e486. 6 indexed citations
14.
Weintraub, Lauren, et al.. (2012). Graft rejection in pediatric liver transplant patients with Epstein‐Barr viremia and post‐transplant lymphoproliferative disease. Pediatric Transplantation. 16(5). 458–464. 8 indexed citations
15.
Shapiro, Mark, Birte Wistinghausen, Peter S. Midulla, & Cynthia Chin. (2011). Metastatic osteosarcoma presenting as a singlepulmonary microembolus. Journal of Pediatric Surgery. 46(3). 574–576. 5 indexed citations
16.
17.
Madan, Rebecca Pellett, Andrew Campbell, Gail F. Shust, et al.. (2009). A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients. Transplantation. 87(9). 1318–1324. 45 indexed citations
18.
Weisfeld‐Adams, James D., Yitzchak Frank, Vinod Havalad, et al.. (2008). Diagnostic challenges in a child with familial hemophagocytic lymphohistiocytosis type 3 (FHLH3) presenting with fulminant neurological disease. Child s Nervous System. 25(2). 153–9. 15 indexed citations
19.
Lee, Chien‐Kuo, Regina Raz, Ramón Gimeno, et al.. (2002). STAT3 Is a Negative Regulator of Granulopoiesis but Is Not Required for G-CSF-Dependent Differentiation. Immunity. 17(1). 63–72. 207 indexed citations
20.
Wistinghausen, Birte, et al.. (1997). Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11. British Journal of Haematology. 99(3). 575–577. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoki Sakata Breakdown of academic impact, for papers by Federica Galaverna Breakdown of academic impact, for papers by Silvy Lachance Breakdown of academic impact, for papers by Janet Poole Breakdown of academic impact, for papers by Abraham S. Kanate Breakdown of academic impact, for papers by Pierre Péterlin Breakdown of academic impact, for papers by Riad El Fakih Breakdown of academic impact, for papers by Javier López‐Jiménez Breakdown of academic impact, for papers by Tulio E. Rodriguez Breakdown of academic impact, for papers by Kyung‐Nam Koh
Rankless by CCL
2026